How to Help Your Patients Save Money on Potaba: A Provider's Guide to Savings Programs

Medication cost is one of the most common barriers to treatment adherence — and for patients on Potaba (potassium aminobenzoate), the monthly expense can be significant. This guide is designed for urologists, rheumatologists, and dermatologists who want to proactively help their patients navigate insurance coverage, discount programs, and cost-reduction options for Potaba in 2026.

Understanding Potaba Pricing: What Your Patients Are Facing

The retail cash price for a 30-day supply of potassium aminobenzoate (generic Potaba) typically ranges from $100 to $150 per month, depending on pharmacy and location. For patients treated for Peyronie's disease — where therapy often continues for 12 months or longer — this represents a total out-of-pocket exposure of $1,200–$1,800 or more over the course of treatment.

Prescription discount programs like GoodRx and SingleCare can reduce this cost to approximately $80–$120 per month in many markets. Even with this reduction, Potaba is not a trivial expense — particularly for patients on fixed incomes or those without prescription drug coverage.

Strategy 1: Proactively Verify Insurance Formulary Coverage

Before sending a Potaba prescription to the pharmacy, have your staff check the patient's formulary status. Most commercial health insurance plans list potassium aminobenzoate at Tier 2 or Tier 3. Tier 2 co-pays are typically $15–$45 per fill; Tier 3 co-pays range from $30–$80 per fill.

For Medicare Part D patients, coverage varies by plan. Some plans include potassium aminobenzoate; others do not. Use the Medicare Plan Finder at medicare.gov to look up whether a specific Part D plan covers it, or call the plan's pharmacy benefits line directly.

Strategy 2: Submit Prior Authorization Proactively

Some plans require prior authorization for Potaba — particularly for off-label indications or when the diagnosis doesn't map to a commonly covered condition. The worst-case scenario for your patient is locating the medication at a pharmacy, presenting the prescription, and then discovering the claim is denied. A prior authorization request can prevent this.

Required documentation for PA requests typically includes: the patient's diagnosis (ICD-10 code), the clinical rationale for Potaba (explain fibrotic condition), and documentation that first-line alternatives were considered or tried. A brief letter of medical necessity from you can significantly speed the PA process.

Strategy 3: Recommend Prescription Discount Programs

For patients who pay cash or whose co-pay exceeds the discount price, prescription discount cards are a practical tool. The most widely used are:

GoodRx: Accepted at most major chains and thousands of independent pharmacies. Patients search goodrx.com for "potassium aminobenzoate" and bring the coupon to the pharmacy.

SingleCare: Another widely accepted program. Prices are comparable to GoodRx and sometimes lower depending on the pharmacy.

NeedyMeds Discount Card: A nonprofit-sponsored discount card with broad pharmacy acceptance. Particularly useful for uninsured patients.

Provide patients with a printed or digital reference to these programs at the time of prescribing. Include this in your after-visit summary template for Potaba prescriptions.

Strategy 4: Consider Compounding as a Cost and Access Solution

For patients in areas where commercial Potaba is chronically unavailable or prohibitively expensive, compounding pharmacies can offer a practical alternative. Compounded potassium aminobenzoate — particularly in powder or custom capsule form — may be less expensive than commercial Potaba at retail prices in some markets.

When writing a compounding prescription, specify: active ingredient (potassium aminobenzoate), dose per administration, total daily dose, form (capsule or powder), and any relevant excipient instructions. Ensure the compounding pharmacy is 503A-accredited and uses USP-grade bulk material.

Strategy 5: Patient Assistance Programs (PAPs)

As of 2026, there is no widely publicized manufacturer PAP specifically for brand Potaba from Glenwood LLC. However, resources like NeedyMeds.org and RxAssist.org maintain databases of both manufacturer PAPs and nonprofit assistance programs. Encourage patients to search these sites using "potassium aminobenzoate."

For patients who are uninsured and below a certain income threshold, some state pharmaceutical assistance programs (SPAPs) and nonprofit organizations may provide help. Your social worker or patient navigator can assist with these applications.

Strategy 6: Help Patients Use medfinder to Reduce Wasted Trips

When patients can't find Potaba at their pharmacy, they sometimes pay the cash price at the first pharmacy that has it — even if it's significantly higher than the discount price elsewhere. By recommending medfinder alongside discount programs, you help patients both locate the medication and pay the lowest possible price. medfinder calls pharmacies to confirm availability; then GoodRx or SingleCare handles the pricing at that pharmacy.

Building a Cost-Transparency Checklist for Your Practice

Consider adding a brief Potaba cost-support checklist to your after-visit summary template:

☐ Insurance formulary checked — tier: ___

☐ Prior authorization submitted (if required)

☐ GoodRx/SingleCare coupon provided to patient

☐ Preferred pharmacy notified (independent/specialty pharmacy)

☐ medfinder.com recommended for locating the medication

☐ Compounding discussed if commercial product unavailable

For guidance on helping patients locate Potaba, see How to Help Your Patients Find Potaba in Stock: A Provider's Guide.